![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
IDX184, A Liver-Targeted Nucleotide HCV Polymerase Inhibitor:
Results of a First-in-Man Safety and Pharmacokinetic Study
|
|
|
44th EASL April 23-26 2009 Copenhagen
Reported by Jules Levin
X.J. Zhou, K. Pietropaolo, J. Sullivan-Bolyai, B. Kuca, W. Liu, L. Xu, B. Belanger, S. Khan and D. Mayers
Idenix Pharmaceuticals, Inc., Cambridge, MA, USA
![DisCon-1.gif](../images/050709/DisCon-1.gif)
![background-2.gif](../images/050709/background-2.gif)
![Toward-3.gif](../images/050709/Toward-3.gif)
![Methond-4.gif](../images/050709/Methond-4.gif)
![Demo-5.gif](../images/050709/Demo-5.gif)
![Pharka-6.gif](../images/050709/Pharka-6.gif)
![NM-7.gif](../images/050709/NM-7.gif)
![Dose-8.gif](../images/050709/Dose-8.gif)
![levels-9.gif](../images/050709/levels-9.gif)
![butRem-10.gif](../images/050709/butRem-10.gif)
![N-11.gif](../images/050709/N-11.gif)
![etal-12.gif](../images/050709/etal-12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|